Caribbean News Global

GSK begins shipping influenza vaccine doses for the 2025-26 flu season in Canada 

  • GSK supports seasonal flu immunization in Canada with domestic supply of Fluviral vaccine in advance of flu season

MISSISSAUGA, Ontario – GSK Canada (GlaxoSmithKline Inc.) announced it has started shipping doses of its trivalent seasonal influenza vaccine, Fluviral, to Canadian provinces in preparation for the 2025-26 flu season.

  • GSK supports seasonal flu immunization in Canada with domestic supply of Fluviral vaccine in advance of flu season

MISSISSAUGA, Ontario – GSK Canada (GlaxoSmithKline Inc.) announced it has started shipping doses of its trivalent seasonal influenza vaccine, Fluviral, to Canadian provinces in preparation for the 2025-26 flu season.

Fluviral is a trivalent vaccine for use in adults and children greater than 6 months of age to protect against influenza virus types A and B contained in the vaccine.

Influenza, commonly referred to as the flu, is estimated to cause over 12,000 hospitalizations and 3,500 deaths each year in Canada, ranking it among the 10 leading causes of death in the country.  According to Health Canada, annual vaccination is the most effective way to reduce the risk of flu and its potentially serious outcomes. The Public Health Agency of Canada recommends yearly vaccination for anyone aged six months or older who does not have contraindications, ideally before flu season starts.

Canada’s supply of Fluviral is being produced at our vaccines manufacturing facility in Ste-Foy, Quebec, which has been providing influenza vaccine for Canadians since 1997. The site currently produces the majority share of Canada’s seasonal influenza vaccine supply and, in the event of an influenza pandemic, is the primary supplier of the country’s pandemic flu vaccine.

Every year, different strains of flu circulate during the season. The World Health Organization (WHO) studies worldwide trends and recommends the strains to be included in the annual flu vaccine.

For egg-based influenza vaccines for the 2025-26 flu season in the Northern Hemisphere, the WHO has recommended including an A/Victoria/4897/2022 (H1N1) pdm09-like virus, an A/Croatia/10136RV/2023 (H3N2)-like virus and a B/Austria/1359417/2021 (B/Victoria lineage)-like virus. The supply of Fluviral for the 2025-26 season complies with these recommendations.

The post GSK begins shipping influenza vaccine doses for the 2025-26 flu season in Canada  appeared first on Caribbean News Global.

3 hours 54 min ago

Global News, Health & Fitness, Latest Articles, News

Health – Dominican Today

SNS designated official medical services provider for 25th Central American and Caribbean Games 2026

Santo Domingo.- The National Health Service (SNS) and the Organizing Committee of the XXV Central American and Caribbean Games Santo Domingo 2026 have signed an agreement designating the Public Health Services Network as the official provider of hospital medical services during the event. The agreement was signed by SNS executive director Dr.

Santo Domingo.- The National Health Service (SNS) and the Organizing Committee of the XXV Central American and Caribbean Games Santo Domingo 2026 have signed an agreement designating the Public Health Services Network as the official provider of hospital medical services during the event. The agreement was signed by SNS executive director Dr. Mario Lama and Committee president José P. Monegro, in the presence of key health sector officials.

Dr. Lama emphasized that the entire hospital network, including doctors, specialists, support staff, and equipment, will be available to ensure the safety and well-being of athletes and participants. The Luis Eduardo Aybar Health City will serve as the main referral center, supported by the Ney Arias Lora and Darío Contreras trauma hospitals. The agreement also includes mobile dental units, a polyclinic in the Olympic Village, and coordinated medical services in all provinces hosting competitions.

The agreement, notarized by Dr. Lucía Collado, will remain in effect from July 1 to August 30, 2026, with the option of renewal.

19 hours 40 min ago

Health, Sports

PAHO/WHO | Pan American Health Organization

WHO updates list of essential medicines to include key cancer, diabetes treatments

WHO updates list of essential medicines to include key cancer, diabetes treatments

Cristina Mitchell

8 Sep 2025

WHO updates list of essential medicines to include key cancer, diabetes treatments

Cristina Mitchell

8 Sep 2025

1 day 1 hour ago

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Roche receives EU CE mark for Contivue for neovascular age-related macular degeneration

Basel: Roche has announced that it has received the EU CE mark for its Port Delivery Platform containing Susvimo, which will now be known as Contivue in the EU. The device comprises the eye implant through which Susvimo is delivered, and four ancillary devices to initially fill, insert, refill, and remove the implant (if required).

Basel: Roche has announced that it has received the EU CE mark for its Port Delivery Platform containing Susvimo, which will now be known as Contivue in the EU. The device comprises the eye implant through which Susvimo is delivered, and four ancillary devices to initially fill, insert, refill, and remove the implant (if required).

Susvimo (ranibizumab injection) 100 mg/mL is currently under review with the European Medicines Agency (EMA) for the treatment of neovascular age-related macular degeneration(nAMD. With immediate and predictable durability, Contivue with Susvimo provides continuous delivery of a customised formulation of ranibizumab directly to the eye.

“Susvimo offers people living with nAMD the opportunity to maintain their vision with as few as two treatments per year,” said Levi Garraway, MD, PhD, Roche’s Chief Medical Officer and Head of Global Product Development. “Moreover, this sustained delivery brings substantial long-term clinical benefits, as demonstrated by the seven years of follow-up data from the LADDER study.”

Three clinical studies contribute to the EMA’s evaluation of efficacy and safety of Contivue with Susvimo in nAMD: one pivotal Phase III study, Archway, and two supportive studies, the Phase II LADDER study and the open-label long-term extension study Portal. Data from Archway showed patients treated with Contivue with Susvimo achieved and maintained vision outcomes equivalent to monthly intravitreal (IVT) ranibizumab injections.

New long-term data from the LADDER study, presented at the 25th EURETINA Congress in Paris, France, shows that Contivue with Susvimo provides good visual outcomes with stable retinal anatomy over the longer term. In the 59 patients continuously treated with Contivue with Susvimo over seven years, best-corrected visual acuity (BCVA) was 70.4 letters at baseline and 63.2 letters at seven years, an average decline of only seven letters approximately over that time for patients who were at or near peak levels at the time of enrolment after receiving three intravitreal injections of standard of care. Half of all patients had approximately 20/40 vision at seven years (Snellen visual acuity test). Contivue with Susvimo durability was maintained in approximately 95% of patients.

“The seven-year results from the LADDER study powerfully demonstrate the long-term outcomes delivered by Contivue with Susvimo,” said study investigator Carl C. Awh, MD, FASR, Tennessee Retina, Nashville, TN, USA . “For patients with nAMD, the sustained drug delivery of Contivue with Susvimo may provide superior visual outcomes compared to the well-demonstrated average decline in vision associated with long-term intravitreal injections.’’

The port delivery platform devices have been specifically engineered for use with a customized formulation of ranibizumab that is gradually released over time. Roche has several molecules in the pipeline with potential for use with the port delivery platform for continued growth and expansion.

Age-related macular degeneration (AMD) is a condition that affects the part of the eye that provides sharp, central vision needed for activities like reading. Neovascular or ‘wet’ AMD (nAMD) is an advanced form of the disease that can cause rapid and severe vision loss if left untreated. It develops when new and abnormal blood vessels grow uncontrolled under the macula, causing swelling, bleeding and/or fibrosis. Worldwide, around 20 million people are living with nAMD – the leading cause of vision loss in people over the age of 60 – and the condition will affect even more people around the world as the global population ages.

2 days 8 hours ago

News,Ophthalmology,Ophthalmology News,Industry,Pharma News,Latest Industry News

Health – Demerara Waves Online News- Guyana

Lola Doll shot several times, hospitalised in critical condition

Well-known Guyanese artiste, model and businesswoman Lolita “Lola Doll” Callender was shot several times on Saturday night outside her residence in Texas Square, East Ruimveldt, police sources said. The 33-year-old woman was shot eight times to her right leg, hands, face, and neck while she was sitting in her motorcar. Ms Callender was rushed to ...

Well-known Guyanese artiste, model and businesswoman Lolita “Lola Doll” Callender was shot several times on Saturday night outside her residence in Texas Square, East Ruimveldt, police sources said. The 33-year-old woman was shot eight times to her right leg, hands, face, and neck while she was sitting in her motorcar. Ms Callender was rushed to ...

2 days 12 hours ago

Crime, Health, News, critical condition, hospitalised, Lolita "Lola Doll" Callender, shooting

Health – Dominican Today

Study conducted by the IIBI warns of resistant bacteria in Dominican rivers

The Institute for Innovation in Biotechnology and Industry (IIBI) warned that the presence of bacteria resistant to common antibiotics in the country’s main rivers poses a serious health risk.

The institution recommended strengthening environmental monitoring, preventing self-medication, and improving wastewater treatment.

The Institute for Innovation in Biotechnology and Industry (IIBI) warned that the presence of bacteria resistant to common antibiotics in the country’s main rivers poses a serious health risk.

The institution recommended strengthening environmental monitoring, preventing self-medication, and improving wastewater treatment.

The discovery stems from research on the Ozama, Isabela, Yaque del Norte, and Yaque del Sur rivers, where microorganisms such as Escherichia coli, Klebsiella, Pseudomonas, and Acinetobacter were detected

These bacteria, classified by the World Health Organization (WHO) as priority pathogens due to their drug resistance, are associated with intestinal, urinary, respiratory, and skin infections.

The study was conducted by a team of young Dominican scientists from IIBI, in collaboration with Intec, Isfodosu, and ISA universities, led by Dr. Edian F. Franco and Professor Luis O. Maroto. 

The research employed whole-genome sequencing and metagenomics techniques, an approach that goes beyond conventional microbiology and allows for identifying not only which bacteria are present, but also their capabilities. This approach facilitates the tracking of contamination routes, the identification of critical discharges, and the guidance of mitigation actions.

When these organisms are dispersed in the environment, the chances of them reaching food, drinking water, or people who use rivers for bathing or work increase. 

In the case of infection, treatments may become more protracted, more expensive, and less effective.

The IIBI, an institution directed by engineer Osmar Olivo, calls on citizens to care for and rescue our water sources, remembering that river water is vital to the health, agricultural production, the economy, and daily life of all Dominicans.

Findings by area

In Ozama and Isabela, both in densely populated urban areas, resistant bacteria linked to domestic and industrial discharges were detected.

In Yaque del Norte, a route was traced from the springs to agricultural and urban areas, verifying how the presence of intestinal bacteria such as E. coli, Klebsiella, and Enterobacter increases.

In Yaque del Sur, sediments revealed DNA from Vibrio cholerae (cholera) and Salmonella (gastroenteritis), which poses a risk if the water is used without treatment.

A problem with daily impact

River water is crucial for cooking, washing, irrigating crops, and sustaining the economy. If antibiotics lose effectiveness, common health problems could turn into serious and costly illnesses.

The WHO warns that the misuse of antibiotics accelerates bacterial resistance. Therefore, the IIBI insists on the urgency of implementing immediate measures that include responsible antibiotic use, adequate wastewater treatment, and strengthening environmental monitoring.

Science and youth training

Along with the research leaders, undergraduate and graduate students from Intec, Isfodosu, and ISA participated. Among them were Irene Zulay Ortiz Confesor, Lázaro M. Acosta Rivera, Argeny Lorenzo Ovando, Camila Del Rosario, Albert Duarte, Víctor V. Calderón, and Roberto Bonnelly, among others.

The project, funded by the MESCYT–FONDOCyT (National Meteorological Service of the Basin of Cyclone and the Basin of Cyclone), has generated international publications, and complete monitoring data from the Yaque River will be released in the coming months.

3 days 2 hours ago

Health, Local

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Fifth Tragic Loss: Orthopaedician dies of heart attack at 45

Berhampur: In an unfortunate incident, an associate professor in the Department of Orthopaedics at MKCG Medical College and Hospital in Ganjam district passed away due to a heart attack at the age of just 45.  

Berhampur: In an unfortunate incident, an associate professor in the Department of Orthopaedics at MKCG Medical College and Hospital in Ganjam district passed away due to a heart attack at the age of just 45.  

The doctor, identified as Dr. Sangram Sabat, had been complaining of chest pain and was taken to the medical college on Friday morning. However, despite immediate medical attention, he could not be saved.

Also read- 39-year-old Cardiac Surgeon dies of cardiac arrest while on duty

MKCG Superintendent Durga Madhab Satapathy told TOI that Dr. Sabat had already passed away by the time he reached the hospital.

Notably, doctors between the ages of 30–45 are increasingly becoming vulnerable to heart-related issues. Factors like long working hours, immense pressure, sedentary lifestyles, and poor eating habits contribute to conditions like high blood pressure and high cholesterol, which in turn raise the risk of heart attacks and cardiac arrests. 

This marks the fifth such case in the past week of doctors succumbing to cardiovascular complications.

Medical Dialogues recently reported a series of tragic incidents involving the sudden deaths of four doctors. Dr Gradlin Roy, a 39-year-old consultant cardiac surgeon at Saveetha Medical College, died from massive cardiac arrest while on duty rounds. Similarly, 40-year-old Dr. Prakash Gupta, an anaesthesia specialist at Goyal Hospitals in Jodhpur, also succumbed to cardiac arrest. A 39-year-old Dr Gaurav Mittal, a critical care specialist and Dr Devan, a 42-year-old associate professor from the cardiology department at Manakula Vinayaga Medical College, both passed away following massive heart attacks.

Also read- Fourth doctor lost in a week: Chennai Cardiologist dies of cardiac arrest

3 days 4 hours ago

State News,News,Health news,Odisha,Doctor News,Latest Health News,Notifications,Recent Health News

Health Archives - Barbados Today

BUT backs hotline in urgent call for youth mental health support



The Barbados Union of Teachers (BUT) has hailed the 24-hour mental health hotline as a vital service for the island’s most vulnerable students, urging the government to further expand youth-focused support amid a sharp rise in calls from young people.

Responding to new statistics from Chief Medical Officer Dr Kenneth George showing that the hotline has handled more than 6 500 calls in just over a year, and that the number of people seeking mental health support has doubled since the pandemic, BUT President Rudy Lovell said the service highlights the growing demand for accessible mental health care.

“Particularly striking is the revelation that 40 per cent of these calls have come from children and teenagers,” Lovell told Barbados TODAY.

“This underscores what teachers and school leaders have long observed, that many of our young people are grappling with immense pressures, often silently. The hotline provides them with a safe, confidential space to reach out for help at any hour of the day or night.”

Lovell’s comments come against the backdrop of violent altercations at several schools over the last academic year, which included not only student-on-student violence, but also incidents of student-on-teacher aggression.

Schools cannot simply focus on academic achievement, as emotional and psychological support is needed to help nurture well-rounded citizens, he insisted.

Lovell said: “As educators, we recognise that academic success is inseparable from emotional and psychological well-being. We therefore applaud this initiative and encourage its continued strengthening, particularly in the areas of youth outreach, school partnerships, and awareness campaigns that destigmatise mental health challenges.

“The Barbados Union of Teachers pledges its support in working alongside health professionals, families, and communities to ensure that every child knows help is available and that no student feels alone in moments of crisis.” (SB)

The post BUT backs hotline in urgent call for youth mental health support appeared first on Barbados Today.

3 days 4 hours ago

Health, Local News

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Monthly Olezarsen Significantly Lowers Triglycerides in High-Risk Patients: NEJM

A new study published in The New England Journal of Medicine found that a once-monthly injection of olezarsen reduced triglyceride levels by up to 60% in adults with moderate hypertriglyceridemia and elevated cardiovascular risk, with over 80% achieving normal triglyceride levels at 6 months.

Olezarsen, an experimental N-acetylgalactosamine–conjugated antisense oligonucleotide, targets messenger RNA of apolipoprotein C-III, which is a protein that impairs the clearance of triglycerides from the bloodstream. By blocking this protein, olezarsen facilitates faster removal of triglycerides, addressing a core mechanism of the disorder.

The phase 3 trial enrolled 1,349 participants who had either moderate hypertriglyceridemia, defined as triglyceride levels between 150 and 499 milligrams per deciliter, combined with elevated cardiovascular risk, or severe hypertriglyceridemia with levels exceeding 500 mg/dL. The participants were randomly assigned to receive monthly subcutaneous injections of olezarsen at either 50 milligrams or 80 milligrams, or to receive a placebo.

The primary outcome was the percent change in triglyceride levels after 6 months of treatment. These results found triglyceride levels fell by 58.4% with the 50-mg dose and 60.6% with the 80-mg dose when compared to placebo. Both results were statistically highly significant, with confidence intervals confirming consistency across the patient groups.

The study population was diverse, with a median age of 64 years and 40% women. The baseline median triglyceride level was 238.5 mg/dL, with most patients falling between 190.5 and 307.5 mg/dL. Also, reductions were consistent across both olezarsen dosage groups, highlighting the robust efficacy of the drug.

The incidence of serious adverse events was similar between the drug-treated groups and the placebo group, indicating that the therapy does not appear to introduce new risks despite its powerful lipid-lowering effects.

Overall, the results position olezarsen as a promising new option for patients struggling with high triglycerides, particularly those at elevated risk for heart attacks, strokes, or pancreatitis. By achieving reductions of more than half in triglyceride levels, the effect of olezarsen size surpasses most current therapies, like fibrates or omega-3 fatty acids, which typically deliver more modest improvements.

Source:

Bergmark, B. A., Marston, N. A., Prohaska, T. A., Alexander, V. J., Zimerman, A., Moura, F. A., Kang, Y. M., Weinland, J., Murphy, S. A., Goodrich, E. L., Zhang, S., Li, D., Banach, M., Stroes, E., Lu, M. T., Tsimikas, S., Giugliano, R. P., & Sabatine, M. S. (2025). Targeting APOC3 with olezarsen in moderate hypertriglyceridemia. The New England Journal of Medicine,. https://doi.org/10.1056/nejmoa2507227

3 days 13 hours ago

Cardiology-CTVS,Cardiology & CTVS News,Top Medical News

Health – Dominican Today

Research finds antibiotic-resistant bacteria in major Dominican rivers

Santo Domingo.- The Institute for Innovation in Biotechnology and Industry (IIBI) has warned that antibiotic-resistant bacteria found in the Dominican Republic’s main rivers pose a serious threat to public health. The institute urges stronger environmental monitoring, improved wastewater treatment, and responsible use of antibiotics to mitigate risks.

Santo Domingo.- The Institute for Innovation in Biotechnology and Industry (IIBI) has warned that antibiotic-resistant bacteria found in the Dominican Republic’s main rivers pose a serious threat to public health. The institute urges stronger environmental monitoring, improved wastewater treatment, and responsible use of antibiotics to mitigate risks.

Research conducted on the Ozama, Isabela, Yaque del Norte, and Yaque del Sur rivers detected bacteria such as Escherichia coli, Klebsiella, Pseudomonas, and Acinetobacter. These microorganisms, classified by the WHO as priority pathogens due to their drug resistance, are linked to intestinal, urinary, respiratory, and skin infections. The study, led by Dr. Edian F. Franco and Professor Luis O. Maroto, used whole-genome sequencing and metagenomics to identify bacterial presence and capabilities, allowing researchers to trace contamination sources and inform mitigation strategies.

Key findings revealed that Ozama and Isabela rivers, in densely populated urban areas, showed contamination from domestic and industrial discharges. Yaque del Norte exhibited rising intestinal bacteria levels along its course through agricultural and urban zones. In Yaque del Sur, sediment samples contained DNA from Vibrio cholerae and Salmonella, posing a risk if water is used untreated.

The IIBI stressed that river water is vital for cooking, washing, irrigation, and the economy, and that the spread of resistant bacteria could make common infections more severe, expensive, and difficult to treat. The research, conducted with students from INTEC, ISFODOSU, and ISA and funded by MESCYT–FONDOCyT, has already produced international publications, with further monitoring results forthcoming.

3 days 20 hours ago

Health

Health – Dominican Today

United for Excellence: Latin American leaders to participate in 2025 International Health Quality and Safety Forum

Santo Domingo.- The second edition of the International Forum on Quality and Safety in Health will take place on Wednesday, September 17, at the Hotel Aloft Santo Domingo, bringing together specialists from the Dominican Republic, Brazil, Colombia, and Chile to discuss the challenges of modern medicine and strategies to strengthen more humane, saf

Santo Domingo.- The second edition of the International Forum on Quality and Safety in Health will take place on Wednesday, September 17, at the Hotel Aloft Santo Domingo, bringing together specialists from the Dominican Republic, Brazil, Colombia, and Chile to discuss the challenges of modern medicine and strategies to strengthen more humane, safe, and sustainable healthcare systems.

The event will feature keynote presentations on topics such as digital transformation, artificial intelligence, critical care management, innovation in healthcare, and the importance of human talent in driving excellence. Speakers include Dr. Gastón Gabin of CEMDOE, Dr. Maril Núñez, Cleber Sampaio from Brazil, Dr. Carlos Kerguelen from Colombia, Dr. Alejandro Mauro from Chile, and Dr. Francisco Méndez of CEDIMAT.

With this initiative, CEMDOE reaffirms its commitment to promoting innovation, safety, and quality in healthcare, positioning the Dominican Republic as part of the global dialogue on medical transformation and excellence in patient care.

3 days 22 hours ago

Health, Uncategorized

Pages